Abstract
Intramuscular myxoma is a benign neoplasm currently classified among soft tissue tumors of uncertain differentiation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Notes
- 1.
GNAS: alternative splicing of downstream exons of this gene (also named GNAS complex locus and guanine nucleotide-binding protein alpha-stimulating activity polypeptide 1) results in different forms of the stimulatory G-protein alpha subunit, a key element of the classical signal transduction pathway linking G protein-coupled receptors (GPCR) with the activation of adenylyl cyclase and ultimately a variety of cell activities.
Suggested Readings
Allen (2000) Myxoma is not a single entity: a review of the concept of myxoma. Ann Diagn Pathol 4(2):99–123
Delaney (2009) GNAS1 mutations occur more commonly than previously thought in intramuscular myxoma. Mod Pathol 22(5):718–724
Fletcher (2020) WHO classification of tumours of soft tissue and bone (5th edition)
Vescini (2019) Mazabraud’s syndrome: a case report and up-to-date literature review. Endocr Metab Immune Disord Drug Targets 19(6):885–893
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2021 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Mocellin, S. (2021). Intramuscular Myxoma. In: Soft Tissue Tumors . Springer, Cham. https://doi.org/10.1007/978-3-030-58710-9_136
Download citation
DOI: https://doi.org/10.1007/978-3-030-58710-9_136
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-58709-3
Online ISBN: 978-3-030-58710-9
eBook Packages: MedicineMedicine (R0)